19 results on '"Janette B. Myers"'
Search Results
2. The CaMKII holoenzyme structure in activation-competent conformations
- Author
-
Janette B. Myers, Vincent Zaegel, Steven J. Coultrap, Adam P. Miller, K. Ulrich Bayer, and Steve L. Reichow
- Subjects
Science - Abstract
Ca2+/calmodulin-dependent protein kinase II (CaMKII) forms a 12 subunit holoenzyme central to synaptic plasticity. Here the authors report a 3D structure of the CaMKII holoenzyme in an activation-competent state obtained by single particle EM, and suggest a role for the intrinsically disordered linker domain in facilitating cooperative activation.
- Published
- 2017
- Full Text
- View/download PDF
3. Correction: Publisher Correction: The CaMKII holoenzyme structure in activation-competent conformations
- Author
-
Janette B. Myers, Vincent Zaegel, Steven J. Coultrap, Adam P. Miller, K. Ulrich Bayer, and Steve L. Reichow
- Subjects
Science - Abstract
Nature Communications 8: Article number: 15742 (2017); Published 7 June 2017; Updated 25 May 2018 The previously published version of this Article contained an error in Figure 7. In panel b, the % Compact subunits was shown as ‘
- Published
- 2018
- Full Text
- View/download PDF
4. Multivalency regulates activity in an intrinsically disordered transcription factor
- Author
-
Sarah Clark, Janette B Myers, Ashleigh King, Radovan Fiala, Jiri Novacek, Grant Pearce, Jörg Heierhorst, Steve L Reichow, and Elisar J Barbar
- Subjects
Medicine ,Science ,Biology (General) ,QH301-705.5 - Published
- 2018
- Full Text
- View/download PDF
5. Connexin-46/50 in a dynamic lipid environment resolved by CryoEM at 1.9 Å
- Author
-
Steve L. Reichow, Jeremy Copperman, Bassam G. Haddad, Daniel M. Zuckerman, Janette B. Myers, Craig C. Yoshioka, Jonathan A. Flores, and Kimberly A. Dolan
- Subjects
0301 basic medicine ,Protein Conformation ,Science ,General Physics and Astronomy ,Connexin ,02 engineering and technology ,Molecular Dynamics Simulation ,Connexins ,Ion Channels ,Article ,General Biochemistry, Genetics and Molecular Biology ,Turn (biochemistry) ,03 medical and health sciences ,Molecular dynamics ,Protein structure ,Cryoelectron microscopy ,lcsh:Science ,Nanodisc ,Ion transporter ,Ion transport ,Multidisciplinary ,Chemistry ,Gap junction ,Gap Junctions ,Biological Transport ,Membrane structure and assembly ,General Chemistry ,021001 nanoscience & nanotechnology ,Structure and function ,030104 developmental biology ,Biophysics ,lcsh:Q ,Permeation and transport ,lipids (amino acids, peptides, and proteins) ,Molecular modelling ,0210 nano-technology - Abstract
Gap junctions establish direct pathways for cells to transfer metabolic and electrical messages. The local lipid environment is known to affect the structure, stability and intercellular channel activity of gap junctions; however, the molecular basis for these effects remains unknown. Here, we incorporate native connexin-46/50 (Cx46/50) intercellular channels into a dual lipid nanodisc system, mimicking a native cell-to-cell junction. Structural characterization by CryoEM reveals a lipid-induced stabilization to the channel, resulting in a 3D reconstruction at 1.9 Å resolution. Together with all-atom molecular dynamics simulations, it is shown that Cx46/50 in turn imparts long-range stabilization to the dynamic local lipid environment that is specific to the extracellular lipid leaflet. In addition, ~400 water molecules are resolved in the CryoEM map, localized throughout the intercellular permeation pathway and contributing to the channel architecture. These results illustrate how the aqueous-lipid environment is integrated with the architectural stability, structure and function of gap junction communication channels., The local lipid environment is known to affect the structure, stability and intercellular channel activity of gap junctions, however, the molecular basis for these effects remains unknown. Here authors report the CryoEM structure of Cx46/50 lipid-embedded channels, by which they reveal a lipid-induced stabilization to the channel.
- Published
- 2020
6. Expediting cryo-EM sample preparation using design of experiments
- Author
-
Rose Marie Haynes and Janette B. Myers
- Subjects
Biophysics - Published
- 2023
7. Structure of native lens connexin 46/50 intercellular channels by cryo-EM
- Author
-
Bassam G. Haddad, Daniel M. Zuckerman, Craig C. Yoshioka, Steve L. Reichow, Dror S. Chorev, Janette B. Myers, Carol V. Robinson, and Susan O'Neill
- Subjects
Models, Molecular ,0301 basic medicine ,Gene isoform ,Cryo-electron microscopy ,Connexin ,medicine.disease_cause ,Cataract ,Connexins ,Article ,03 medical and health sciences ,0302 clinical medicine ,Lens, Crystalline ,otorhinolaryngologic diseases ,medicine ,Humans ,Amino Acid Sequence ,Peptide sequence ,Mutation ,Multidisciplinary ,Chemistry ,Cryoelectron Microscopy ,Gap junction ,Gap Junctions ,Connexin 26 ,030104 developmental biology ,medicine.anatomical_structure ,Membrane protein ,Lens (anatomy) ,Biophysics ,030217 neurology & neurosurgery - Abstract
Gap junctions establish direct pathways for cell-to-cell communication, through the assembly of twelve subunits (connexins) that form intercellular channels connecting neighboring cells. Co-assembly of different connexin isoforms produces channels with unique properties, and enables communication across cell-types. To gain access into the structural underpinnings of connexin co-assembly, we used single particle CryoEM to determine the structure of native lens gap junction channels, composed of connexin-46 and connexin-50 (Cx46/50). We provide the first comparative analysis to connexin-26 (Cx26), which together with computational studies elucidates key energetic features governing gap junction perm-selectivity. Cx46/50 adopts an open-state conformation that is unique from the Cx26 crystal structure, yet appears to be stabilized by a conserved set of hydrophobic anchoring residues. ‘Hot spots’ of genetic mutations linked to hereditary cataract formation map to the core structural-functional elements identified in Cx46/50, rationalizing many of the disease-causing effects.
- Published
- 2018
8. Connexin-46/50 in a dynamic lipid environment resolved by CryoEM at 1.9 Å
- Author
-
Daniel M. Zuckerman, Kimberly A. Dolan, Janette B. Myers, Jeremy Copperman, Craig C. Yoshioka, Steve L. Reichow, Bassam G. Haddad, and Jonathan A. Flores
- Subjects
0303 health sciences ,Intercellular channel activity ,Chemistry ,030302 biochemistry & molecular biology ,Gap junction ,Connexin ,Turn (biochemistry) ,03 medical and health sciences ,Molecular dynamics ,Membrane ,Biophysics ,Lipid bilayer ,Nanodisc ,030304 developmental biology - Abstract
Gap junctions establish direct pathways for connected cells and tissues to transfer metabolic and electrical messages1. The local lipid environment is known to affect the structure, stability and intercellular channel activity of gap junctions2-5; however, the molecular basis for these effects remains unknown. To gain insight toward how gap junctions interact with their local membrane environment, we used lipid nanodisc technology to incorporate native connexin-46/50 (Cx46/50) intercellular channels into a dual lipid membrane system, closely mimicking a native cell-to-cell junction. Structural characterization of Cx46/50 lipid-embedded channels by single particle CryoEM revealed a lipid-induced stabilization to the channel, resulting in a 3D reconstruction at 1.9 Å resolution. Together with all-atom molecular dynamics (MD) simulations and 3D heterogeneity analysis of the ensemble CryoEM data, it is shown that Cx46/50 in turn imparts long-range stabilization to the dynamic local lipid environment that is specific to the extracellular lipid leaflet of the two opposed membranes. In addition, nearly 400 water molecules are resolved in the CryoEM map, localized throughout the intercellular permeation pathway and contributing to the channel architecture. These results illustrate how the aqueous-lipid environment is integrated with the architectural stability, structure and function of gap junction communication channels, and demonstrates the ability of CryoEM to effectively characterize dynamical protein-lipid interactions.
- Published
- 2020
- Full Text
- View/download PDF
9. Visualization of Protein-Lipid Interactions in Connexin-46/50 Intercellular Channels by Cryo-EM and MD-Simulation
- Author
-
Steve L. Reichow, Craig C. Yoshioka, Kimberly A. Dolan, Daniel M. Zuckerman, Janette B. Myers, Bassam G. Haddad, and Jonathan A. Flores
- Subjects
Chemistry ,Cryo-electron microscopy ,Biophysics ,Connexin ,Intracellular ,Visualization - Published
- 2020
10. Author response: Multivalency regulates activity in an intrinsically disordered transcription factor
- Author
-
Radovan Fiala, Janette B. Myers, Grant Pearce, Steve L. Reichow, Ashleigh King, Sarah A. Clark, Elisar Barbar, Jiri Novacek, and Jörg Heierhorst
- Subjects
Chemistry ,Transcription factor ,Cell biology - Published
- 2018
11. Visualization of Protein-Lipid Interactions in Connexin-46/50 Intercellular Communication Channels at 2.1 Å Resolution
- Author
-
Kimberly A. Dolan, Steve L. Reichow, Daniel M. Zuckerman, Jonathan A. Flores, Craig C. Yoshioka, Bassam G. Haddad, and Janette B. Myers
- Subjects
Chemistry ,Resolution (electron density) ,Biophysics ,Connexin ,Instrumentation ,Intracellular ,Visualization - Published
- 2019
12. The CaMKII holoenzyme structure in activation-competent conformations
- Author
-
Steve L. Reichow, Adam P. Miller, Vincent Zaegel, Steven J. Coultrap, K. Ulrich Bayer, and Janette B. Myers
- Subjects
0301 basic medicine ,Multidisciplinary ,Chemistry ,Science ,Protein subunit ,Protein domain ,General Physics and Astronomy ,General Chemistry ,Article ,General Biochemistry, Genetics and Molecular Biology ,Cell biology ,03 medical and health sciences ,030104 developmental biology ,Protein structure ,Förster resonance energy transfer ,Holoenzymes ,Ca2+/calmodulin-dependent protein kinase ,Synaptic plasticity ,Transferase - Abstract
The Ca2+/calmodulin-dependent protein kinase II (CaMKII) assembles into large 12-meric holoenzymes, which is thought to enable regulatory processes required for synaptic plasticity underlying learning, memory and cognition. Here we used single particle electron microscopy (EM) to determine a pseudoatomic model of the CaMKIIα holoenzyme in an extended and activation-competent conformation. The holoenzyme is organized by a rigid central hub complex, while positioning of the kinase domains is highly flexible, revealing dynamic holoenzymes ranging from 15–35 nm in diameter. While most kinase domains are ordered independently, ∼20% appear to form dimers and, Ca2+/calmodulin-dependent protein kinase II (CaMKII) forms a 12 subunit holoenzyme central to synaptic plasticity. Here the authors report a 3D structure of the CaMKII holoenzyme in an activation-competent state obtained by single particle EM, and suggest a role for the intrinsically disordered linker domain in facilitating cooperative activation.
- Published
- 2017
13. Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for Brucellosis
- Author
-
Thomas E. Edwards, Donald D. Lorimer, Kayode K. Ojo, Erkang Fan, Douglas R. Davies, Ryan Choi, Frederick S. Buckner, David M. Dranow, Janette B. Myers, Stephen M. Boyle, Lynn K. Barrett, Wesley C. Van Voorhis, Ranae M. Ranade, S.N. Hewitt, and Zhongsheng Zhang
- Subjects
0301 basic medicine ,Bacterial Diseases ,Acylation ,lcsh:Medicine ,Pathology and Laboratory Medicine ,Biochemistry ,law.invention ,chemistry.chemical_compound ,law ,Zoonoses ,Medicine and Health Sciences ,Aminoacylation ,Enzyme Inhibitors ,Post-Translational Modification ,lcsh:Science ,chemistry.chemical_classification ,Multidisciplinary ,Crystallography ,biology ,Physics ,Condensed Matter Physics ,3. Good health ,Bacterial Pathogens ,Nucleic acids ,Infectious Diseases ,Medical Microbiology ,Physical Sciences ,Recombinant DNA ,Crystal Structure ,Growth inhibition ,Pathogens ,Transfer RNA ,Sequence Analysis ,Research Article ,Neglected Tropical Diseases ,Drug Research and Development ,030106 microbiology ,Trypanosoma brucei ,Research and Analysis Methods ,Microbiology ,Brucellosis ,03 medical and health sciences ,Potency ,Solid State Physics ,Viability assay ,Non-coding RNA ,Molecular Biology Techniques ,Sequencing Techniques ,Microbial Pathogens ,Molecular Biology ,Pharmacology ,Bacteria ,Biology and life sciences ,lcsh:R ,Wild type ,Organisms ,Proteins ,biology.organism_classification ,Tropical Diseases ,Brucella ,Enzyme ,chemistry ,Enzymology ,RNA ,lcsh:Q ,Sequence Alignment ,Brucella melitensis - Abstract
We investigated Brucella melitensis methionyl-tRNA-synthetase (BmMetRS) with molecular, structural and phenotypic methods to learn if BmMetRS is a promising target for brucellosis drug development. Recombinant BmMetRS was expressed, purified from wild type Brucella melitensis biovar Abortus 2308 strain ATCC/CRP #DD-156 and screened by a thermal melt assay against a focused library of one hundred previously classified methionyl-tRNA-synthetase inhibitors of the blood stage form of Trypanosoma brucei. Three compounds showed appreciable shift of denaturation temperature and were selected for further studies on inhibition of the recombinant enzyme activity and cell viability against wild type B. melitensis strain 16M. BmMetRS protein complexed with these three inhibitors resolved into three-dimensional crystal structures and was analyzed. All three selected methionyl-tRNA-synthetase compounds inhibit recombinant BmMetRS enzymatic functions in an aminoacylation assay at varying concentrations. Furthermore, growth inhibition of B. melitensis strain 16M by the compounds was shown. Inhibitor-BmMetRS crystal structure models were used to illustrate the molecular basis of the enzyme inhibition. Our current data suggests that BmMetRS is a promising target for brucellosis drug development. However, further studies are needed to optimize lead compound potency, efficacy and safety as well as determine the pharmacokinetics, optimal dosage, and duration for effective treatment. Published version
- Published
- 2016
14. Correction: Publisher Correction: The CaMKII holoenzyme structure in activation-competent conformations
- Author
-
Steve L. Reichow, Steven J. Coultrap, K. Ulrich Bayer, Janette B. Myers, Adam P. Miller, and Vincent Zaegel
- Subjects
0301 basic medicine ,03 medical and health sciences ,030104 developmental biology ,Multidisciplinary ,Ca2+/calmodulin-dependent protein kinase ,Published Erratum ,Science ,General Physics and Astronomy ,General Chemistry ,Computational biology ,General Biochemistry, Genetics and Molecular Biology ,Mathematics - Abstract
Nature Communications 8: Article number: 15742 (2017); Published 7 June 2017; Updated 25 May 2018 The previously published version of this Article contained an error in Figure 7. In panel b, the % Compact subunits was shown as ‘
- Published
- 2018
15. Increasing the Structural Coverage of Tuberculosis Drug Targets
- Author
-
David M. Dranow, Loren Baugh, David A. Fox, Dmitri Serbzhinskiy, Robin Stacy, Stephen N. Hewitt, Marvin M. Muruthi, Matthew C. Clifton, Ryan Choi, Darren W. Begley, Ngoc Tran, Wesley C. Van Voorhis, Sally Lyons-Abbott, Don Lorimer, Jan Abendroth, Ariel Abramov, Bart L. Staker, Alberto J. Napuli, Katie Thompkins, Brandy M. Taylor, Isabelle Phan, Shellie H. Dieterich, James W. Fairman, Elizabeth Mundt, Yang Zhang, Garry W. Buchko, Aarthi Sekar, Brianna Armour, Lynn K. Barrett, Peter J. Myler, Janette B. Myers, Thomas E. Edwards, Anna Gardberg, Micah Ferrell, and Lance Stewart
- Subjects
Microbiology (medical) ,Models, Molecular ,Tuberculosis ,Immunology ,Antitubercular Agents ,Quantitative Structure-Activity Relationship ,Computational biology ,Crystallography, X-Ray ,Microbiology ,Article ,Structural genomics ,Mycobacterium ,Mycobacterium tuberculosis ,Bacterial Proteins ,Species Specificity ,Hydrolase ,medicine ,Humans ,Molecular Targeted Therapy ,Databases, Protein ,biology ,Drug discovery ,Active site ,Computational Biology ,Genomics ,biology.organism_classification ,medicine.disease ,Enzyme Activation ,Infectious Diseases ,Biochemistry ,Drug Design ,Proteome ,biology.protein ,Cytidylate kinase - Abstract
High-resolution three-dimensional structures of essential Mycobacterium tuberculosis (Mtb) proteins provide templates for TB drug design, but are available for only a small fraction of the Mtb proteome. Here we evaluate an intra-genus “homolog-rescue” strategy to increase the structural information available for TB drug discovery by using mycobacterial homologs with conserved active sites. Of 179 potential TB drug targets selected for x-ray structure determination, only 16 yielded a crystal structure. By adding 1675 homologs from nine other mycobacterial species to the pipeline, structures representing an additional 52 otherwise intractable targets were solved. To determine whether these homolog structures would be useful surrogates in TB drug design, we compared the active sites of 106 pairs of Mtb and non-TB mycobacterial (NTM) enzyme homologs with experimentally determined structures, using three metrics of active site similarity, including superposition of continuous pharmacophoric property distributions. Pair-wise structural comparisons revealed that 19/22 pairs with >55% overall sequence identity had active site Cα RMSD 85% side chain identity, and ≥80% PSAPF (similarity based on pharmacophoric properties) indicating highly conserved active site shape and chemistry. Applying these results to the 52 NTM structures described above, 41 shared >55% sequence identity with the Mtb target, thus increasing the effective structural coverage of the 179 Mtb targets over three-fold (from 9% to 32%). The utility of these structures in TB drug design can be tested by designing inhibitors using the homolog structure and assaying the cognate Mtb enzyme; a promising test case, Mtb cytidylate kinase, is described. The homolog-rescue strategy evaluated here for TB is also generalizable to drug targets for other diseases.
- Published
- 2014
16. Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for Brucellosis
- Author
-
Douglas R. Davies, Stephen M. Boyle, Janette B. Myers, Erkang Fan, David M. Dranow, Thomas E. Edwards, Wesley C. Van Voorhis, Lynn K. Barrett, S.N. Hewitt, Zhongsheng Zhang, Ryan Choi, Frederick S. Buckner, Ranae M. Ranade, Kayode K. Ojo, and Donald D. Lorimer
- Subjects
0301 basic medicine ,Protein Conformation ,Drug target ,lcsh:Medicine ,Methionine-tRNA Ligase ,Brucellosis ,Inhibitory Concentration 50 ,03 medical and health sciences ,Drug Discovery ,Brucella melitensis ,medicine ,Amino Acid Sequence ,Enzyme Inhibitors ,lcsh:Science ,Multidisciplinary ,Sequence Homology, Amino Acid ,biology ,Chemistry ,lcsh:R ,Correction ,biology.organism_classification ,medicine.disease ,Virology ,Methionyl-tRNA synthetase ,High-Throughput Screening Assays ,030104 developmental biology ,lcsh:Q - Abstract
We investigated Brucella melitensis methionyl-tRNA-synthetase (BmMetRS) with molecular, structural and phenotypic methods to learn if BmMetRS is a promising target for brucellosis drug development. Recombinant BmMetRS was expressed, purified from wild type Brucella melitensis biovar Abortus 2308 strain ATCC/CRP #DD-156 and screened by a thermal melt assay against a focused library of one hundred previously classified methionyl-tRNA-synthetase inhibitors of the blood stage form of Trypanosoma brucei. Three compounds showed appreciable shift of denaturation temperature and were selected for further studies on inhibition of the recombinant enzyme activity and cell viability against wild type B. melitensis strain 16M. BmMetRS protein complexed with these three inhibitors resolved into three-dimensional crystal structures and was analyzed. All three selected methionyl-tRNA-synthetase compounds inhibit recombinant BmMetRS enzymatic functions in an aminoacylation assay at varying concentrations. Furthermore, growth inhibition of B. melitensis strain 16M by the compounds was shown. Inhibitor-BmMetRS crystal structure models were used to illustrate the molecular basis of the enzyme inhibition. Our current data suggests that BmMetRS is a promising target for brucellosis drug development. However, further studies are needed to optimize lead compound potency, efficacy and safety as well as determine the pharmacokinetics, optimal dosage, and duration for effective treatment.
- Published
- 2016
17. Multivalency regulates activity in an intrinsically disordered transcription factor
- Author
-
F. Grant Pearce, Radovan Fiala, Ashleigh King, Elisar Barbar, Jiri Novacek, Jörg Heierhorst, Steve L. Reichow, Janette B. Myers, and Sarah A. Clark
- Subjects
0301 basic medicine ,Cytoplasmic Dyneins ,QH301-705.5 ,Science ,Structural Biology and Molecular Biophysics ,Intrinsically disordered proteins ,General Biochemistry, Genetics and Molecular Biology ,chemistry.chemical_compound ,03 medical and health sciences ,0302 clinical medicine ,Transcription (biology) ,transcription factors ,Animals ,Drosophila Proteins ,Humans ,Binding site ,Biology (General) ,Transcription factor ,Gene ,030304 developmental biology ,0303 health sciences ,General Immunology and Microbiology ,electron microscopy ,Chemistry ,C-terminus ,General Neuroscience ,dynamic complexes ,Correction ,Dyneins ,General Medicine ,multivalency ,NMR ,Cell biology ,030104 developmental biology ,Drosophila melanogaster ,Structural biology ,Gene Expression Regulation ,Medicine ,DNA ,030217 neurology & neurosurgery ,Research Article ,Human - Abstract
The transcription factor ASCIZ (ATMIN, ZNF822) has an unusually high number of recognition motifs for the product of its main target gene, the hub protein LC8 (DYNLL1). Using a combination of biophysical methods, structural analysis by NMR and electron microscopy, and cellular transcription assays, we developed a model that proposes a concerted role of intrinsic disorder and multiple LC8 binding events in regulating LC8 transcription. We demonstrate that the long intrinsically disordered C-terminal domain of ASCIZ binds LC8 to form a dynamic ensemble of complexes with a gradient of transcriptional activity that is inversely proportional to LC8 occupancy. The preference for low occupancy complexes at saturating LC8 concentrations with both human and Drosophila ASCIZ indicates that negative cooperativity is an important feature of ASCIZ-LC8 interactions. The prevalence of intrinsic disorder and multivalency among transcription factors suggests that formation of heterogeneous, dynamic complexes is a widespread mechanism for tuning transcriptional regulation., eLife digest Proteins help to regulate almost every process in the body, and come in various forms, sizes and purposes. Cells contain thousands of different proteins, but not every protein is needed at all times. To create new proteins, the information on a gene first needs to be transcribed into RNA (template molecules of the DNA) in a process known as transcription. A complex machinery inside the cell then uses the copy as a template to assemble the protein. So-called transcription factors (also proteins) can switch the copying process on or off by binding to the start point of a gene. They can act alone or in complex with other proteins. The transcription factor called ASCIZ, for example, helps to regulate the production of a protein called LC8. LC8 attaches to more than 100 different proteins and plays an important role in many cell processes. Therefore, fine-tuning its production is essential. The shape of a protein is critical to its purpose. Like most proteins, transcription factors are made up of chains of amino acids that fold into a specific three-dimensional (3D) structurewith a region that recognizes and binds to a specific DNA sequence. But many transcription factors also contain flexible, ‘disordered’ regions that do not fold into a rigid 3D shape. These may help to control the activity of genes, but their exact role is unclear. ASCIZ contains an exceptionally long, disordered region that has multiple positions for binding LC8 along its chain. Previous research has shown that ASCIZ binds to the LC8 gene and increases transcription to produce more LC8 proteins. Once the protein levels are high enough, LC8 is thought to bind to the disordered region of ASCIZ and switch off transcription. Human ASCIZ proteins have 11 binding sites for LC8 molecules, while fruit flies have seven. Until now it was not clear why so many different binding sites exist. To address this question, Clark et al. combined biophysical, structural and molecular biology techniques to analyze proteins from humans and fruit flies and to test their role in human cells. This revealed that LC8 and ASCIZ form a dynamic mixture of complexes, instead of a single fully-occupied complex. As the number of LC8 molecules bound to ASCIZ increased, the rate of transcription dropped. However, all of the binding sites were rarely fully occupied. Instead, three to four attached LC8 molecules seemed to be sufficient to ensure that LC8 levels remain balanced. When the number of LC8 molecules exceeded this value, the attachment rate for additional LC8 slowed down. So, even when there was an excess of LC8, most of the human ASCIZ binding sites were only partially filled. This way, the production of LC8 proteins was slowed, rather than fully shut down. As a result, the cells were able to fine-tune the transcription rate of LC8 and maintain a stable and balanced pool of these proteins. This work suggests that disordered regions on transcription factors could help to keep cellular systems steady in the face of changing conditions. In the future, the combination of methods used here could reveal new information about other proteins with disordered regions.
- Full Text
- View/download PDF
18. Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for Brucellosis.
- Author
-
Kayode K Ojo, Ranae M Ranade, Zhongsheng Zhang, David M Dranow, Janette B Myers, Ryan Choi, Steve Nakazawa Hewitt, Thomas E Edwards, Douglas R Davies, Donald Lorimer, Stephen M Boyle, Lynn K Barrett, Frederick S Buckner, Erkang Fan, and Wesley C Van Voorhis
- Subjects
Medicine ,Science - Abstract
We investigated Brucella melitensis methionyl-tRNA-synthetase (BmMetRS) with molecular, structural and phenotypic methods to learn if BmMetRS is a promising target for brucellosis drug development. Recombinant BmMetRS was expressed, purified from wild type Brucella melitensis biovar Abortus 2308 strain ATCC/CRP #DD-156 and screened by a thermal melt assay against a focused library of one hundred previously classified methionyl-tRNA-synthetase inhibitors of the blood stage form of Trypanosoma brucei. Three compounds showed appreciable shift of denaturation temperature and were selected for further studies on inhibition of the recombinant enzyme activity and cell viability against wild type B. melitensis strain 16M. BmMetRS protein complexed with these three inhibitors resolved into three-dimensional crystal structures and was analyzed. All three selected methionyl-tRNA-synthetase compounds inhibit recombinant BmMetRS enzymatic functions in an aminoacylation assay at varying concentrations. Furthermore, growth inhibition of B. melitensis strain 16M by the compounds was shown. Inhibitor-BmMetRS crystal structure models were used to illustrate the molecular basis of the enzyme inhibition. Our current data suggests that BmMetRS is a promising target for brucellosis drug development. However, further studies are needed to optimize lead compound potency, efficacy and safety as well as determine the pharmacokinetics, optimal dosage, and duration for effective treatment.
- Published
- 2016
- Full Text
- View/download PDF
19. Correction: Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for Brucellosis.
- Author
-
Kayode K Ojo, Ranae M Ranade, Zhongsheng Zhang, David M Dranow, Janette B Myers, Ryan Choi, Steve Nakazawa Hewitt, Thomas E Edwards, Douglas R Davies, Donald Lorimer, Stephen M Boyle, Lynn K Barrett, Frederick S Buckner, Erkang Fan, and Wesley C Van Voorhis
- Subjects
Medicine ,Science - Abstract
[This corrects the article DOI: 10.1371/journal.pone.0160350.].
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.